OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300200$10.9855

Beijing Comens New Materials Co Ltd

Specialty ChemicalsVerified

The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.13, indicating a conservative leverage position. However, its liquidity position is assessed as medium, with negative net cash after subtracting total debt. The price-to-book ratio of 2.9 suggests that the company is trading at a premium to its book value, while the price-to-earnings ratio of 45.51 indicates a high valuation relative to earnings. In terms of profitability, the company's return on equity (ROE) of 6.38% and return on assets (ROA) of 4.08% are below the typical thresholds for high-performing specialty chemical firms. These metrics suggest that the company is generating modest returns relative to its equity and asset base. Gross profit of 318.39 million CNY and operating income of 114.81 million CNY reflect a healthy gross margin, but the net income of 103.98 million CNY indicates that operating expenses are consuming a significant portion of gross profit. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's operating cash flow is negative at -16.40 million CNY, which is a concern for its ability to fund operations without external financing. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a modest increase in revenue, but the next fiscal year outlook is not yet available. The company's capital expenditure of -40.57 million CNY suggests a reduction in investment in new projects or capacity expansion. The risk assessment highlights a liquidity risk due to negative net cash, and the dilution risk is currently low. Recent filings and transcripts have not revealed any major strategic shifts or significant operational changes. The company's financial performance remains stable, but the lack of positive momentum in cash flow and capital spending raises questions about its long-term growth potential.

30-day price · 300200+2.24 (+24.9%)
Low$8.97High$11.68Close$11.22As of20 May, 00:00 UTC
Profile
CompanyBeijing Comens New Materials Co Ltd
Ticker300200.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Beijing Comens New Materials Co Ltd is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.13, indicating a conservative leverage position. However, its liquidity position is assessed as medium, with negative net cash after subtracting total debt. The price-to-book ratio of 2.9 suggests that the company is trading at a premium to its book value, while the price-to-earnings ratio of 45.51 indicates a high valuation relative to earnings. In terms of profitability, the company's return on equity (ROE) of 6.38% and return on assets (ROA) of 4.08% are below the typical thresholds for high-performing specialty chemical firms. These metrics suggest that the company is generating modest returns relative to its equity and asset base. Gross profit of 318.39 million CNY and operating income of 114.81 million CNY reflect a healthy gross margin, but the net income of 103.98 million CNY indicates that operating expenses are consuming a significant portion of gross profit. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's operating cash flow is negative at -16.40 million CNY, which is a concern for its ability to fund operations without external financing. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a modest increase in revenue, but the next fiscal year outlook is not yet available. The company's capital expenditure of -40.57 million CNY suggests a reduction in investment in new projects or capacity expansion. The risk assessment highlights a liquidity risk due to negative net cash, and the dilution risk is currently low. Recent filings and transcripts have not revealed any major strategic shifts or significant operational changes. The company's financial performance remains stable, but the lack of positive momentum in cash flow and capital spending raises questions about its long-term growth potential.
Key takeaways
  • The company maintains a conservative debt structure with a low debt-to-equity ratio of 0.13.
  • ROE and ROA are below industry benchmarks, indicating suboptimal returns on equity and assets.
  • Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
  • Negative operating cash flow and a high price-to-earnings ratio suggest a high valuation with limited cash generation.
  • The company's capital expenditure is negative, signaling a reduction in investment in growth initiatives.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.32B
Gross profit$318.4M
Operating income$114.8M
Net income$104.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$16.4M
CapEx-$40.6M
Free cash flow$32.9M
Total assets$2.55B
Total liabilities$916.1M
Total equity$1.63B
Cash & equivalents
Long-term debt$216.7M
Valuation
Market price$10.98
Market cap$4.73B
Enterprise value$4.95B
P/E45.5
Reported non-GAAP P/E
EV/Revenue3.8
EV/Op income43.1
EV/OCF
P/B2.9
P/Tangible book2.9
Tangible book$1.63B
Net cash-$216.7M
Current ratio1.5
Debt/Equity0.1
ROA4.1%
ROE6.4%
Cash conversion-16.0%
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300200Activity
Op margin8.7%0.4% medp25 -8.0% · p75 16.0%above median
Net margin7.9%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin24.1%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity13.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 01:56 UTCJob: b6164585